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Abstract 
Zearalenone (ZEN) is a phenolic resorcylic acid lactone, produced by several Fusarium 
species causing reproductive disorders such as abortion and stillbirth in livestock resulting 
from hyperestrogenism. A monoclonal antibody (mcAb) specific to zearalenone was produced 
from hybridoma cell line 5A8. It was generated by the fusion of Sp2/0 myeloma cells with 
spleen cells isolated from Balb/c mice with highest-titer (1: 64,000, v/v). The mice were 
immunized intraperitoneally with zearalenone–cationic bovine serum albumin (ZEN-cBSA). 
ZEN-cOVA conjugate was used as coating antigen to test titer of mice serum. Hybridoma cells 
were grown on cell culture media supplemented with carbohydrates (CHO) respectively. 
Monoclonal antibody produced by hybridoma in vitro belongs to the immunoglobulin subtype 
IgG1 with specific antibody titer 0.70. The most effective culture medium for hybridoma clones 
was supplemented with maltose that achieved best titer at 1.473 as determined by icELISA. 
The use of supplemented cell culture media is an effective approach to improve the 
production of monoclonal-antibody, better hybridoma growth and viability. 
Keywords: Monoclonal antibody, zearalenone, hybridoma technology. 
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INTRODUCTION 
Mycotoxins are known as poisonous metabolites of 
fungi that exist on farmland or in the process of producing, 
transporting, handling or storing farm commodities and 
foodstuff (Zhang et al., 2014), contaminating up to 25% 
grain crops every year (Brenn-Struckhofova et al., 2007). 
Considering the substantial risks of public health and 
economic, Zearalenone (ZEN), has received much 
attention among scientists who attempt to detect 
mycotoxins in foodstuff and fodder in recent years (Bucheli 
et al., 2008). ZEN contamination of cereal, feed, and the 
environment are recognized as a worldwide problem. ZEN 
can be identified with the systematic name 3,4,5,6,9,10-
hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacy-
clotetradecin-1,7(8H)-dione or 6-(10-hydroxy-6- oxo-trans-
1-un-decenyl)-β-resorcylic-acid-lactone. Together with 
other compounds, it belongs to the group of resorcylic acid 
lactone (RALs) carrying a keto group and an olefinic double 
bond (Figure S1) (Budavari et al., 1989). It is a nonsteroidal 
mycotoxin possessing the estrogen-like activity and has 
been associated with pubertas praecox, endometrial 
neoplasms, endometrial hyperplasia as well as carcinoma 
of the uterine cervix (Shim et al., 2009). 
Hybridoma technology was first invented for the 
production of monoclonal antibodies in 1975 (Bretton et al., 
1994) (Figure S2). Cell culture comprises isolation of cells 
from (in vivo) and their growth under a controlled 
environment (in vitro) in the sufficient supply of culture 
media and nutrients (Cooke et al., 2008). The mAbs are 
clinically significant homogeneous and mono-specific 
scientific biomolecules produced from hybridoma cells by 
hybridoma technology (Zhang, 2012). Since their 
discovery, these molecules have been used as research 
tools and have revolutionized the fields of biotechnology, 
immunology, diagnostics, and medicine (Priyabrat et al., 
2014). Improvements in hybridoma technology are based 
on research demand, cost effectiveness, human labor, and 
reduced development time. Similarly, the production of 
mAbs requires multiple phases, long duration, and high 
cost. CHO is provided largely in the form of glucose as a 
carbon source for the hybridoma cells. In some cases, 
glucose is substituted with other sugars to enhance cell 
growth, viability and protein production (Altamirano et al., 
2004; Wilkens et al., 2011). The aim of this study was the 
production of mcAb against ZEN by CHO supplemented 
culture media for the establishment of immunoassay 
purposes. 
 
MATERIALS AND METHODS 
Ethics Statement 
All animal experiments were carried out according to 
the rules by the Animal Welfare Committee of Fujian 
Agriculture and Forestry University, Fuzhou, China. 
 
Materials 
Zearalenone, bovine serum albumin (BSA), ovalbumin 
(OVA), Tween 20, dimethyl sulfoxide (DMSO), 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC), and N-
hydroxysuccinimide (NHS), Goat anti-mouse-peroxidase 
conjugate, substrate solution 3, 3′,5,5′-tetramethylbenzidine 
(TMB), Polyethylene glycol (PEG 1500), hypoxanthine (H), 
aminopterin (A), and thymidine (T) were purchased from 
Sigma Chemical Co. (St. Louis, MO). 96-well immunoassay 
plates were purchased from (Maxisorp; Nunc). Freund’s 
complete and incomplete adjuvant, Roswell Park Memorial 
Institute medium (RPMI-1640), fetal bovine serum (FBS), 
and penicillin-streptomycin were obtained from Gibco 
Laboratories (Grand Island, NY). All other chemicals and 
organic solvents used were of reagent grade or better. 
 
Mice and Cell Lines 
Virus-free, 6-8 weeks old, three female BALB/c mice 
were obtained from Shanghai SLAC Laboratory Animal 
Co., Ltd. (SLAC) China. The murine myeloma cell line 
Sp2/0 was obtained from Shanghai cell culture bank 
(SIBS), China. All cell lines were confirmed to be 
Mycoplasma-free by RT-PCR analysis. 
 
Preparation of Conjugates 
The hapten of ZEN was conjugated to the modified 
carrier proteins, (cationic BSA; immunogen) and (cationic 
OVA; coating antigen) according to the method described 
previously (Figure S3 and S4). 
 
Immunizations and serum characterization 
Three female Balb/c mice were immunized 
intraperitoneally, at two-week intervals, with 100 μg of ZEN-
cBSA in 0.01 M PBS in a total volume of 200μl. After 4 
times of injection, the titer and sensitivity of antibody in the 
serum was determined by improved icELISA. 
 
Optimization of CHO supplemented cell culture media 
The four test media contained RPMI-1640, 10% FBS, 
and penicillin/streptomycin, supplemented with glucose 
(control), fructose, galactose and maltose at a 
concentration of 15 mg/mL each as carbon sources. Cells 
were cultured in a humidified atmosphere of 5% CO2 at 
37°C to optimize media components. 
 
Fusion and Screening 
Spleen cells were isolated from the immunized mice 
and mixed with Sp2/0 murine myeloma cells at a ratio of 
1:10 in the presence of 1mL 50% PEG. Cell fusion and 
hybridoma culture procedures were carried out essentially 
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following previous reports by limiting dilution (Ling et al., 
2014; Ling et al., 2018; Ling, 2015). 
 
Cell density 
Static cultures using several 25 cm
2
 flasks (Corning, 
Sigma-Aldrich) were inoculated with an initial cell density of 
10
5
 cells/ml following incubation at 37°C in 5% CO2. One 
flask was used every time a cell count was accomplished 
after 3 d, 6 d, and 9 d respectively to determine the cell 
density by the trypan blue exclusion method (Louis, 2011) 
with some modifications. The cells were successfully 
passaged each time into new flasks with fresh media. 
 
Statistical analysis 
Data are presented as mean SD. Appropriate 
statistical tests were performed using GraphPad Prism. 
One-way ANOVA, followed by Dunnett’s multiple 
comparisons test was used for experiments with more than 
3 groups. P values of less than 0.05 were considered 
significant. 
 
RESULTS 
Preparation of Immunogen and Coating Antigen  
The results of the ZEN-carrier proteins conjugation 
were confirmed by gel electrophoresis. The gel results 
indicated that ZEN-cBSA and ZEN-cOVA conjugates were 
successfully conjugated as they traveled faster in the gel 
compared to slower movements of standard proteins i.e., 
BSA and OVA respectively due to the difference in charges 
(Figure 1). The protein concentration in the conjugates was 
determined by bicinchoninic acid assay (BCA). 
 
       2            1                                         2           1 
                          
              (a).                                                   (b). 
Fig. 1. Coomassie blue-stained gel electrophoresis. The analysis 
revealed successful cross-linking of ZEN molecules with cBSA 
and cOVA. (a). lane 1, BSA standard; lane 2, ZEN-cBSA; (b). lane 
1, ZEN-cOVA; lane 2, OVA standard. 
 
Serum anti-ZEN titer 
Serum titers of the immunized BALB/c mice were 
subsequently determined by icELISA. The results showed 
that mouse 2 achieved the highest titer (1: 64,000, v/v) of 
anti-ZEN (Figure 2), and selected for cell fusion with Sp2/0 
cells. 
 
Production and characterization of mAb in selected 
CHO media 
Supernatants of hybridoma cells were determined 
after 9 d post fusion for the reactivity with ZEN by icELISA, 
which resulted in 10 positive clones. One clone was 
selected using limiting dilutions method, and was 
characterized as 5A8G1 (Figure S5) with highest-titer (OD: 
1.473) in maltose supplemented media, other CHO 
showed lower antibody titers i.e. galactose (OD: 1.21), 
fructose (OD: 1.20), sucrose (OD: 0.60) and lowest in 
glucose as a control (OD: 0.35) respectively (Figure 3), with 
statistically significant differences (P<0.05). The isotype 
determination showed that 5A8G1 mAb was IgG1 (Figure 
4). 
 
 
 
Fig. 2. Mouse anti-zearalenone antibody titer assayed by icELISA 
demonstrated Mice 2 showed the highest antibody titer (1: 64,000, 
v/v) as compared to control. 
 
 
Fig. 3. Effect of CHO supplemented cell culture media in vitro on 
the production of mAb. After 9 d of 5A8G1 growth, the highest titer 
of 1.47 was obtained in maltose media. Glucose media was used 
as a control (P < 0.05).  
 
Cell density 
Viable cell densities were calculated by harvesting 
hybridoma cells after 9 d culture in vitro. Maltose 
supplementation increased cell densities up to 1.23 
million/mL compared to the control of 0.45 million/mL, the 
difference was statistically significant (P<0.05) (Figure 5). 
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Fig. 4. The isotyping of 5A8G1 as determined by icELISA.  
 
 
Fig. 5. Effect of CHO supplemented media on 5A8G1 cell viability 
in vitro. The cells were harvested after 9 days. Glucose was used 
as a control (P<0.05). 
 
DISCUSSION 
Hybridoma technology has been a significant and 
essential platform for producing high-quality mAbs (Zhang, 
2012). It permits the generation of therapeutic antibodies in 
a native form being a classical and established route of 
generating specific antibodies all around the globe 
(Glukhova, 2016). The mAbs are clinically significant 
homogeneous and mono-specific scientific biomolecules 
produced from hybridoma cells by hybridoma technology 
(Zhang, 2012). Since their discovery, these molecules have 
been used as research tools and have revolutionized the 
fields of biotechnology, immunology, diagnostics, and 
medicine. 
In this study, we produced and characterized mAb 
against Zearalenone (ZEN). ZEN being a hapten was 
conjugated with larger carrier proteins (cationic proteins) 
such as cOVA and cBSA that induce a strong immune 
response in mouse. The conjugation was confirmed with 
Coomassie blue-stained non-denaturing agarose gel 
electrophoresis analysis (Tsai and Lee, 2011). The analysis 
showed that the migration speed of the conjugates was 
faster than that of carrier proteins, indicating that the 
conjugated products carried more negative charges, and 
the net charge of the conjugates became more negative 
than that of the carrier proteins (Wang et al., 2014). 
ZEN-cBSA was used for immunization and ZEN-
cOVA was applied as ELISA coating antigen. ZEN-specific 
antibody-secreting hybridomas were obtained. Since the 
mAb reacted with ZEN in icELISA assay, the antibodies 
were non-conformational (Kindt et al., 2007). Monoclonal 
antibodies produced by the hybridomas were in the IgG1. 
Since secondary antibodies were specific for mouse 
immunoglobulins, non-immune mouse serum was included 
in the assay in order to provide a positive control for mouse 
IgG. The isotype of mcAb produced by this hybridoma cell 
line was IgG1 subclass (Ling et al., 2014). 
Cell culture media have advanced significantly during 
the past few decades, primarily by advancements in media 
supplementation. Various media supplements were tested 
and maltose proved to be the best CHO substitute in cell 
medium which raised mAb titer to a significant level. 
Glucose was used as a control, in general, metabolizes to 
form lactic acid resulting in the hindrance of the cell growth 
or decelerates growth. The substitution of glucose with 
fructose, galactose and maltose favored the growth of 
5A8G1 hybridoma. Maltose supplementation gave the best 
antibody titer in agreement with previous studies (Anand et 
al., 2010). The cell-culture medium provides an artificial 
environment conducive to survival and proliferation of 
cultured cells. Our results showed that maltose 
supplemented media improved cell density and viability 
(Sathya et al., 2008; Trummer et al., 2006). It illustrates 
that, in addition to having the optimal cell line and process, 
it is crucial to have the optimal cell culture medium and 
feed to maximize performance potential. 
 
CONCLUSION 
Progress in cell-culture technology has led to 
substantial enhancement in the production of recombinant 
protein products; however, media development continues 
to remain a key activity that is not completely understood. 
Highest titers of anti-ZEN mAb were obtained with maltose 
supplemented media. So, it is concluded that specific 
monoclonal antibody production, hybridoma density, and 
viability could be enhanced by adding superior nutrients to 
the basal cell culture media in clinical, biological and 
pharmacological applications. The synergistic approach of 
using a selective combination of supplements at specific 
times of addition holds potential to improve antibody 
productivity. 
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